{"name":"Jason Lang, M.D., M.P.H.","slug":"jason-lang-m-d-m-p-h","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"commercially available lansoprazole","genericName":"commercially available lansoprazole","slug":"commercially-available-lansoprazole","indication":"Erosive esophagitis","status":"phase_3"}]}],"pipeline":[{"name":"commercially available lansoprazole","genericName":"commercially available lansoprazole","slug":"commercially-available-lansoprazole","phase":"phase_3","mechanism":"Lansoprazole is a proton pump inhibitor that reduces gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme in the gastric parietal cells.","indications":["Erosive esophagitis","Gastroesophageal reflux disease (GERD)","Zollinger-Ellison syndrome","Duodenal ulcers","Helicobacter pylori eradication"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9BWC1NallnbF9fNUNJS0w1dV9tbWxDLVRJYUZ6WG9fZXZWUUptLTMyU0Q4akJUd1VGNXNIS2Y0emlUWEg1b1hzWXJSMjVSLUMwWlNpZDRmQ1JTRG9LVGRVYg?oc=5","date":"2019-09-25","type":"pipeline","source":"NEJM","summary":"Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma - NEJM","headline":"Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxONDRzSWU3Q1FUdU5ieGlGaFowbjNvVU85LUx0OXA2SHlxMDhoUVI3WXdyZ19FVmpsNmpwc1RHQV80eDN4VFJvVG01dml0S29VblhtZENPMUxVOGtaTWoyNmpXblBXcEp2RkVPb0YtSjdua0p0NFFPQW5NNl9abVFadGdoekZ6WkI1WVRLYkhidkRVSzY0em9mTg?oc=5","date":"2019-01-25","type":"pipeline","source":"healthcare-in-europe.com","summary":"Asthma control: How effective is fish oil really? - healthcare-in-europe.com","headline":"Asthma control: How effective is fish oil really? - healthcare-in","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}